Barentz, a life science ingredients distributor, agreed to acquire a majority stake in Gangwal, a distributor and specialty solutions provider, for $70m. "We have been keen to enter the Indian market for a long time. In Gangwal, we found the right partner due to the similarities in how we do business. We are extremely impressed by the way the Gangwal team has developed the business and the long-term relationships they have built with different global excipient producers. This platform gives us a great leadership team and many opportunities to create new business initiatives to support our global network of suppliers. We are looking forward to accelerating Gangwal’s future strategic growth," Hidde van der Wal, Barentz CEO.